VestGen Advisors’s AbbVie ABBV Stock Holding History

VestGen Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12M	Sell	47,682 -483	-1%	-$104K	0.35%	60
2026 Q1	$10M	Sell	48,165 -1,471	-3%	-$326K	0.27%	75
2025 Q4	$11.3M	Sell	49,636 -4,205	-8%	-$958K	0.48%	43
2025 Q3	$12.5M	Buy	53,841 +14,117	+36%	+$2.87M	0.42%	49
2025 Q2	$7.47M	Buy	39,724 +9,564	+32%	+$1.78M	0.3%	75
2025 Q1	$6.32M	Buy	+30,160	New	+$5.86M	0.29%	77

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VestGen Advisors's ABBV Position: Q2 2026 in Review

VestGen Advisors reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $104K and leaving 47,682 shares worth $12M. The position accounts for 0.35% of the portfolio, ranked #60.

VestGen Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $12.5M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

VestGen Advisors held 47,682 shares of AbbVie worth $12M as of Q2 2026.
VestGen Advisors sold 483 AbbVie shares in Q2 2026, an estimated $104K.
AbbVie made up 0.35% of VestGen Advisors's portfolio in Q2 2026, its #60 holding.
VestGen Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
VestGen Advisors's AbbVie position peaked at $12.5M in Q3 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.